The diet drug Belviq is being withdrawn from the US market because a Belviq safety clinical trial shows an increased occurrence of cancer cases. This February 2020 Belviq FDA Drug Safety Communication announced the Belviq recall, “FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR … More
Main Navigation Menu
➤ Pharmaceutical Drug Injury Lawsuits
➤ Asbestos and Mesothelioma Claims
➤ Benzene Diseases and Cancers Claims
➤ GenX Water Contamination Cancer Cases
➤ Breast Implants Lymphoma Cancer Cases
➤ Free Case Evaluation by Lawyer Tom Lamb
➤ About the Law Offices of Thomas J. Lamb
➤ Frequently Asked Questions (FAQs)
➤ Medical Records Copying Cost Laws
➤ Client Resources: Legal, Medical, and More
➤ Collection of Articles by Our Law Firm
Please know that you can use our Quick Contact Form to tell us a bit about your case.
Recent Articles
Statute of Repose Bars Asbestos-related Claim by Former Power Plant Worker
The estate of a career pipefitter who died from mesothelioma recently lost an appeal on claims that asbestos exposure caused his cancer and the exposure, in the course of his employment, violated the state’s safe place statute. [ This was an appeal of the trial court’s ruling that plaintiff’s … More
Hypophosphatemia Associated With Injectafer Compared To Another Intravenous Anemia Drug
A February 2020 article published by the JAMA medical journal, “Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia — Two Randomized Clinical Trials”, reports on the rate of hypophosphatemia associated with Injectafer compared to another … More
Malignant Diffuse Mesothelioma in Women — A Study of 354 Cases
We reviewed 354 cases of malignant diffuse mesothelioma (MM) in women from a database of 2858 histologically confirmed MM cases. There was a pleural predominance with 78% [ pleural malignant mesothelioma ] and 22% [ peritoneal malignant mesothelioma ]. The pleural tumors consisted of 72% … More
FDA to hold public meeting on testing for asbestos in talc
For the first time in nearly 50 years, the U.S. Food and Drug Administration will examine asbestos testing for talc powders and cosmetics at a hearing on [ February 4, 2020 ]. Regulators are taking a closer look [ at asbestos testing for talc powders and cosmetics ] after finding asbestos, a … More
Hypophosphatemia Is An Injectafer Side Effect With Possible Serious Medical Complications Including Death
Injectafer-induced hypophosphatemia (HPP) is an Injectafer side effect causing muscle weakness, fatigue, and severe nausea. In turn, these hypophosphatemia symptoms can lead to Injectafer-related medical complications including osteomalacia, arrhythmias, cardiac arrest, respiratory failure, and … More